Global Acute Lymphocytic Leukemia (ALL) Therapeutics Market


  • Type: Oncology area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 1041

  • Format: PPT, PDF

Global Acute Lymphocytic Leukemia (ALL) Therapeutics Market Segmented by Type of Therapy (Chemotherapy, Targeted Therapy, Radiation Therapy and Stem Cell Transplantation), Type (Pediatric and Adult) and by Geography (North America, Europe, Asia-Pacific, Latin America and Middle East and Africa) – Growth, Trends and Forecast, 2019-2028

SKU: 1041 Categories: ,

Report Overview

The global Acute Lymphocytic Leukemia (ALL) therapeutics market size stood at around USD 2.42 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Acute lymphocytic/lymphoblastic leukemia (ALL) is a type of cancer that develops from immature lymphocytes. “Acute” here indicates leukemia that quickly progresses and spreads across the body. ALL develops in bone marrow and quickly invades other parts of the body including the liver, spleen, lymph nodes, liver, central nervous system, spleen, central nervous system, and the blood. Symptoms can be non-specific and may include feeling weak and tired, paler skin, bruises, frequent and severe bleeding gums, nose bleeds; weight loss, shortness of breath, and loss of appetite. Various types of therapeutics are used for ALL treatment. Chemotherapy is one of the major therapeutics used for ALL treatment

Market Drivers and Restraints

The market is experiencing growth owing to rise in incidences of acute lymphoblastic leukemia and the number of bone marrow biopsies across the world. In addition, the increase in investment in the R&D of different leukemia and rise in awareness of targeted therapies amongst the population further drive the growth of the ALL therapeutics market. Despite these, the stringent regulatory approvals for the therapeutics and the adverse side effects of the drugs used in the therapy impede the growth of the market worldwide. Also, patent expiry of the blockbuster drugs used in the treatment and the higher costs involved in the therapies limit the growth of the global ALL therapeutics market

1. Global Acute Lymphocytic Leukemia Therapeutics Market Overview………….
A. Market Size
2. Market Growth Drivers and Restraints…………………………………..……………….
A. Market Drivers
I. Rise in the Incidences of Acute Lymphoblastic Leukemia
II. Rise in Number of New Product Approvals
B. Market Restraints
I. Side effects of the treatment
3. Acute Lymphocytic Leukemia Therapeutics Market Segmentation………………
A. By Type of Therapy
I. Chemotherapy
II. Targeted Therapy
III. Radiation Therapy
IV. Stem Cell Transplantation
B. By Type
I. Paediatric
II. Adult
C. By Region
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. South America Market Analysis
V. Middle East and Africa Market Analysis
4. Acute Lymphocytic Leukemia Major Market Share……………….…………………
A. Key Findings
B. Market Analysis, Insights and Forecast
5. Competitive Landscape………………………………………………………….………..
A. Major Players
B. Products in Pipeline
6. Key Company Profiles…………………………………………………………………….
A. Pfizer Company overview, Product & Services, Strategies & Financials
B. BMS Company overview, Product & Services, Strategies & Financials
C. Novartis Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape….…………………………………..
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth………………………………………………………….
A. Key Industry Developments
B. Mergers and Acquisitions
9. Market Opportunities and Future Trends………………………………………………
A. Market Opportunities
I. Increase in number of Clinical Trials
B. Future Trends
10. Conclusion

Market Segmentation

By Type of Therapy:

On the basis of type of therapy, the market of acute lymphocytic leukemia therapeutics market is segmented into chemotherapy, targeted therapy, radiation therapy and stem cell transplantation. Chemotherapy is expected to dominate the type of therapy segment

By Type:

On the basis of type, the acute lymphocytic leukemia market has been segmented into paediatric and adults

According to type, the pediatrics segment generated the highest revenue in 2018 and is expected to maintain its dominance throughout the forecast period. This is attributed to the high incidences of acute lymphocytic/lymphoblastic leukemia among pediatric population. Acute lymphocytic/lymphoblastic leukemia is considered as one of the most common cancer types in pediatric population. Moreover, pediatric population have higher success rate for acute lymphocytic/lymphoblastic leukemia treatments

By Region:

By geography, the Acute Lymphocytic Leukemia therapeutics market is being segmented into North America, Europe, Asia Pacific, South America and Middle East and Africa.

North America is expected to dominate this market, due to the rising number of cases of this disease in the region, owing to genetic factors, environmental factors, and radiation. Moreover, favourable government policies, well-established healthcare infrastructure, and the presence of multinational companies make this region dominant in this market.

Asia-Pacific is also expected to register a high CAGR during the forecast period, owing to several factors, such as high unmet clinical needs, huge patient pool, and the rising awareness about early diagnosis in emerging countries

Top Major Players

The market for acute lymphoblastic leukemia is moderately competitive and consists of the big players as well as the mid-sized companies. Owing to the rising focus of most of the pharmaceutical companies on oncology, it is expected that few new small-sized companies will also penetrate the market in the near future. The major players are Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, SymBio Pharmaceuticals Limited and Genmab AS

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements